Tsumura & Co. (TSMRF) Stock Price, News & Analysis

Company Overview

Tsumura & Co. is a Tokyo‐based pharmaceutical company specializing in the research, development and manufacture of Kampo medicines, which are traditional Japanese herbal remedies rooted in Chinese materia medica. The company’s core business revolves around the extraction, standardization and quality control of crude herbal ingredients, transforming them into prescription‐grade and over‐the‐counter products that are approved under Japan’s national health insurance system.

Leveraging a combination of modern analytical technology and traditional knowledge, Tsumura produces a broad portfolio of Kampo formulations for a range of therapeutic applications, including gastrointestinal health, circulatory support and immune regulation. In addition to its prescription products, the company offers dietary supplements and health‐oriented items designed to meet consumer demand for natural wellness solutions.

While Tsumura’s primary market remains Japan, the company has expanded its reach through overseas subsidiaries and partnerships, notably in the United States and China, where it promotes both research collaborations and product distribution. Throughout its history, Tsumura has emphasized scientific validation of herbal efficacy, investing in clinical trials and collaborative research with academic institutions to bolster the credibility of Kampo medicine in international markets.

Key Stats

• Today's Range: $23.20 to $23.20
• 50-Day Range: $23.20 to $23.20
• 52-Week Range: $23.20 to $25.75
• Volume: N/A
• Average Volume: 400 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 8/06/2026
• Next Earnings (Estimated): 8/06/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:TSMRF
• CIK: N/A
• Web: www.tsumura.co.jp
• Phone: 81 3 6361 7101
• Fax: N/A
• Employees: 4,032
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A